Devin W. Steenkamp, MBChB

Assistant Professor, Medicine

Devin Steenkamp
617.414.2938
720 Harrison Avenue ((DOB-Doctors Office Building)

Biography

Devin Steenkamp is an academic diabetologist with a focus on type 1 diabetes and atypical diabetes phenotypes such as monogenic diabetes. He is the Director of the Clinical Diabetes Program at Boston Medical Center and Boston University School of Medicine and his clinical practice is focused on the use of diabetes technologies in care. In addition, he is the principal investigator on a variety of clinical trials related to diabetes pharmacotherapy and the application of novel diabetes technologies.

Other Positions

  • Member, Evans Center for Interdisciplinary Biomedical Research, Boston University

Education

  • University of Pretoria, MBChB

Publications

  • Published on 10/22/2021

    Ju Z, Piarulli A, Bielick L, Marschall S, Brouillard E, Steenkamp D. Advanced Diabetes Technology Remains Underutilized in Underserved Populations: Early Hybrid Closed-Loop System Experience at an Academic Safety Net Hospital. Diabetes Technol Ther. 2021 Oct 22. PMID: 34569850.

    Read at: PubMed
  • Published on 3/30/2021

    Fantasia KL, Stockman MC, Ju Z, Ortega P, Crable EL, Drainoni ML, Walkey AJ, Bergstrom M, O'Brien K, Steenkamp D. Professional continuous glucose monitoring and endocrinology eConsult for adults with type 2 diabetes in primary care: Results of a clinical pilot program. J Clin Transl Endocrinol. 2021 Mar; 24:100254. PMID: 33898271.

    Read at: PubMed
  • Published on 3/5/2021

    Steenkamp D, Eby EL, Gulati N, Liao B. Adherence and Persistence to Insulin Therapy in People with Diabetes: Impact of Connected Insulin Pen Delivery Ecosystem. J Diabetes Sci Technol. 2021 Mar 05; 1932296821997923. PMID: 33666097.

    Read at: PubMed
  • Published on 1/23/2021

    O'Malley G, Ebekozien O, Desimone M, Pinnaro CT, Roberts A, Polsky S, Noor N, Aleppo G, Basina M, Tansey M, Steenkamp D, Vendrame F, Lorincz I, Mathias P, Agarwal S, Golden L, Hirsch IB, Levy CJ. COVID-19 Hospitalization in Adults with Type 1 Diabetes: Results from the T1D Exchange Multicenter Surveillance Study. J Clin Endocrinol Metab. 2021 01 23; 106(2):e936-e942. PMID: 33165563.

    Read at: PubMed
  • Published on 1/11/2021

    Wirunsawanya K, Chittimoju S, Fantasia KL, Modzelewski KL, Steenkamp D, Alexanian SM. Insulin Requirements in Patients With Type 2 Diabetes Undergoing Bariatric Surgery in the Inpatient Setting and Upon Discharge: A Single-Center Retrospective Analysis of Insulin Management Strategies. Endocr Pract. 2021 Jun; 27(6):538-544. PMID: 34016530.

    Read at: PubMed
  • Published on 12/3/2020

    Vodopivec DM, Thomas DD, Palermo NE, Steenkamp DW, Lee SL. Looking for the Outsider. N Engl J Med. 2020 12 03; 383(23):2275-2281. PMID: 33264549.

    Read at: PubMed
  • Published on 6/16/2020

    Pinardo H, Rubin SJ, Hashemi S, DePietro J, Pearce EN, Ananthakrishnan S, Alexanian SM, Steenkamp DW, Noordzij JP. The use of vitamin D in preventing post-thyroidectomy hypocalcemia: An endocrinologist survey study. Clin Endocrinol (Oxf). 2020 11; 93(5):598-604. PMID: 32469425.

    Read at: PubMed
  • Published on 12/1/2019

    Modzelewski KL, Fantasia KL, Steenkamp DW. Reconsidering Meaningful Outcomes in Diabetes mHealth Research. US Endocrinology. 2019; 2(15):74-76.

    Read at: Custom
  • Published on 10/3/2019

    Fantasia KL, Steenkamp DW. Optimal Glycemic Control in a Patient With HNF1A MODY With GLP-1 RA Monotherapy: Implications for Future Therapy. J Endocr Soc. 2019 Dec 01; 3(12):2286-2289. PMID: 31737858.

    Read at: PubMed
  • Published on 6/1/2019

    Steenkamp D. CONTINUOUS GLUCOSE MONITORING AS A HYPOGLYCEMIA MITIGATION TOOL IN INDIVIDUALS WITH TYPE 1 DIABETES WITH IMPAIRED HYPOGLYCEMIC AWARENESS. Endocr Pract. 2019 Jun; 25(6):619-621. PMID: 31242124.

    Read at: PubMed

View 30 more publications: View full profile at BUMC

View all profiles